{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T23:49:39Z","timestamp":1771026579902,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.bioorg.2019.103020","type":"journal-article","created":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T11:06:39Z","timestamp":1559300799000},"page":"103020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Bridged bicyclic 2,3-dioxabicyclo[3.3.1]nonanes as antiplasmodial agents: Synthesis, structure-activity relationships and studies on their biomimetic reaction with Fe(II)"],"prefix":"10.1016","volume":"89","author":[{"given":"Sarah","family":"D'Alessandro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Alfano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Di Cerbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Brogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Chemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Relitti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margherita","family":"Brindisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Lamponi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ettore","family":"Novellino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Campiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Gemma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Basilico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatella","family":"Taramelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Camilla","family":"Baratto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Pogni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Butini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2019.103020_b0005","unstructured":"World Malaria Report 2018. (04\/03\/2019)."},{"key":"10.1016\/j.bioorg.2019.103020_b0010","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","article-title":"Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study","volume":"16","author":"Amaratunga","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bioorg.2019.103020_b0015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2019.103020_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coph.2018.05.006","article-title":"The antimalarial pipeline","volume":"42","author":"Hooft van Huijsduijnen","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bioorg.2019.103020_b0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.actatropica.2014.12.005","article-title":"Efficacy of Synriam, a new antimalarial combination of OZ277 and piperaquine, against different developmental stages of Schistosoma mansoni","volume":"143","author":"Mossallam","year":"2015","journal-title":"Acta Trop."},{"key":"10.1016\/j.bioorg.2019.103020_b0030","doi-asserted-by":"crossref","first-page":"15159","DOI":"10.1038\/ncomms15159","article-title":"A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance","volume":"8","author":"O'Neill","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2019.103020_b0035","article-title":"In vitro activity of anti-malarial ozonides against an artemisinin-resistant isolate","volume":"16","author":"Baumgaertner","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.bioorg.2019.103020_b0040","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00172-17","article-title":"Plasmodium falciparum K13 mutations differentially impact ozonide susceptibility and parasite fitness in vitro","volume":"8","author":"Straimer","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.bioorg.2019.103020_b0045","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1002\/anie.201512062","article-title":"A click chemistry-based proteomic approach reveals that 1,2,4-trioxolane and artemisinin antimalarials share a common protein alkylation profile","volume":"55","author":"Ismail","year":"2016","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.bioorg.2019.103020_b0050","first-page":"6","article-title":"Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum","author":"Wang","year":"2015","journal-title":"Nature Commun."},{"key":"10.1016\/j.bioorg.2019.103020_b0055","doi-asserted-by":"crossref","first-page":"8328","DOI":"10.1021\/ja00047a076","article-title":"A Regiospecifically O-18 labeled 1,2,4-trioxane - a simple chemical-model system to probe the mechanism(S) for the antimalarial activity of artemisinin (Qinghaosu)","volume":"114","author":"Posner","year":"1992","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2019.103020_b0060","doi-asserted-by":"crossref","first-page":"13002","DOI":"10.1021\/ja985530y","article-title":"Unified mechanistic framework for the Fe(II)-induced cleavage of Qinghaosu and derivatives\/analogues. The first spin-trapping evidence for the previously postulated secondary C-4 radical (vol 120, pg 3316, 1998)","volume":"120","author":"Wu","year":"1998","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2019.103020_b0065","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1471-4922(00)01838-9","article-title":"Possible modes of action of the artemisinin-type compounds","volume":"17","author":"Olliaro","year":"2001","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bioorg.2019.103020_b0070","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/(SICI)1521-3773(19990903)38:17<2580::AID-ANIE2580>3.0.CO;2-J","article-title":"Interaction of Qinghaosu (Artemisinin) with cysteine sulfhydryl mediated by traces of non-heme iron","volume":"38","author":"Wu","year":"1999","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.bioorg.2019.103020_b0075","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1021\/ar000080b","article-title":"How might qinghaosu (artemisinin) and related compounds kill the intraerythrocytic malaria parasite? A chemist's view","volume":"35","author":"Wu","year":"2002","journal-title":"Acc. Chem. Res."},{"issue":"Suppl 1","key":"10.1016\/j.bioorg.2019.103020_b0080","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/0035-9203(94)90468-5","article-title":"The mode of action of antimalarial endoperoxides","volume":"88","author":"Meshnick","year":"1994","journal-title":"Trans R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.bioorg.2019.103020_b0085","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.drup.2004.07.001","article-title":"Artemisinins: mechanisms of action and potential for resistance","volume":"7","author":"Krishna","year":"2004","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bioorg.2019.103020_b0090","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/cmdc.201200383","article-title":"Interactions between artemisinins and other antimalarial drugs in relation to the cofactor model\u2013a unifying proposal for drug action","volume":"7","author":"Haynes","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2019.103020_b0095","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/cmdc.201000508","article-title":"Reactions of antimalarial peroxides with each of leucomethylene blue and dihydroflavins: flavin reductase and the cofactor model exemplified","volume":"6","author":"Haynes","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2019.103020_b0100","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1021\/jo1001559","article-title":"Synthesis of dihydroplakortin, 6-epi-dihydroplakortin, and their C10-desethyl analogues","volume":"75","author":"Gemma","year":"2010","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2019.103020_b0105","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.1016\/j.tetlet.2009.07.137","article-title":"Synthetic studies toward 1,2-dioxanes as precursors of potential endoperoxide-containing antimalarials","volume":"50","author":"Gemma","year":"2009","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2019.103020_b0110","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1021\/jm200686d","article-title":"Synthesis and antiplasmodial activity of bicyclic dioxanes as simplified dihydroplakortin analogues","volume":"54","author":"Gemma","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103020_b0115","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.tetlet.2012.12.075","article-title":"A synthetic strategy to bridged 2,3,8-trioxabicyclo[3,3,1]nonane endoperoxides","volume":"54","author":"Gemma","year":"2013","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2019.103020_b0120","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1039\/C4MD00454J","article-title":"Synthetic spirocyclic endoperoxides: new antimalarial scaffolds","volume":"6","author":"Brindisi","year":"2015","journal-title":"Medchemcomm"},{"key":"10.1016\/j.bioorg.2019.103020_b0125","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1039\/B918600J","article-title":"Insight into the mechanism of action of plakortins, simple 1,2-dioxane antimalarials","volume":"8","author":"Taglialatela-Scafati","year":"2010","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2019.103020_b0130","doi-asserted-by":"crossref","first-page":"8135","DOI":"10.1016\/j.tetlet.2003.09.033","article-title":"Co(thd)(2): a superior catalyst for aerobic epoxidation and hydroperoxysilylation of unactivated alkenes: application to the synthesis of spiro-1,2,4-trioxanes","volume":"44","author":"O'Neill","year":"2003","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2019.103020_b0135","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ejmech.2018.03.024","volume":"150","author":"Vallone","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103020_b0140","doi-asserted-by":"crossref","first-page":"6443","DOI":"10.1021\/jm200768h","article-title":"Comparison of the reactivity of antimalarial 1,2,4,5-tetraoxanes with 1,2,4-trioxolanes in the presence of ferrous iron salts, heme, and ferrous iron salts\/phosphatidylcholine","volume":"54","author":"Bousejra-El Garah","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103020_b0145","doi-asserted-by":"crossref","first-page":"6531","DOI":"10.1021\/jo001265z","article-title":"Iron(II)-induced degradation of antimalarial beta-sulfonyl endoperoxides. Evidence for the generation of potentially cytotoxic carbocations","volume":"66","author":"Szpilman","year":"2001","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2019.103020_b0150","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1021\/jo991585m","article-title":"Mabbs F. Biomimetic Fe(II)-mediated degradation of arteflene (Ro-42-1611). The first EPR spin-trapping evidence for the previously postulated secondary carbon-centered cyclohexyl radical","volume":"65","author":"O'Neill","year":"2000","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2019.103020_b0155","series-title":"Electron Paramagnetic Resonance","article-title":"Spin trapping","author":"Alberti","year":"2008"},{"key":"10.1016\/j.bioorg.2019.103020_b0160","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1021\/jo050385+","article-title":"Dispiro-1,2,4-trioxane analogues of a prototype dispiro-1,2,4-trioxolane: mechanistic comparators for artemisinin in the context of reaction pathways with iron(II)","volume":"70","author":"Tang","year":"2005","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2019.103020_b0165","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1021\/jm0707673","article-title":"Spiro- and dispiro-1,2-dioxolanes: contribution of iron(II)-mediated one-electron vs two-electron reduction to the activity of antimalarial peroxides","volume":"50","author":"Wang","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103020_b0170","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2019.103020_b0175","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1021\/jm300802s","article-title":"Optimization of 4-aminoquinoline\/clotrimazole-based hybrid antimalarials: further structure-activity relationships, in vivo studies, and preliminary toxicity profiling","volume":"55","author":"Gemma","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103020_b0180","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4269\/ajtmh.1993.48.739","article-title":"Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity","volume":"48","author":"Makler","year":"1993","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.bioorg.2019.103020_b0185","unstructured":"International Standards Organization. Biological evaluation of medical devices\u2014Part 5: tests for cytotoxicity: in vitro methods. (2009-06) [2018-08-01]. <https:\/\/www.iso.org\/standard\/36406.html>."},{"key":"10.1016\/j.bioorg.2019.103020_b0190","unstructured":"LigPrep. version 3.5, Schr\u00f6dinger, LLC, New York, NY, 2015."},{"key":"10.1016\/j.bioorg.2019.103020_b0195","unstructured":"MacroModel. version 10.9, Schr\u00f6dinger, LLC, New York, NY, 2015."},{"key":"10.1016\/j.bioorg.2019.103020_b0200","unstructured":"Jaguar, version 8.9, Schr\u00f6dinger, LLC, New York, NY, 2015."},{"key":"10.1016\/j.bioorg.2019.103020_b0205","doi-asserted-by":"crossref","first-page":"11875","DOI":"10.1021\/ja00105a030","article-title":"Accurate first principles calculation of molecular charge-distributions and solvation energies from ab-initio quantum-mechanics and continuum dielectric theory","volume":"116","author":"Tannor","year":"1994","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2019.103020_b0210","unstructured":"Glide, version 6.8, Schr\u00f6dinger, LLC, New York, NY, 2015."},{"key":"10.1016\/j.bioorg.2019.103020_b0215","unstructured":"Prime. version 4.1, Schr\u00f6dinger, LLC, New York, NY, 2015."},{"key":"10.1016\/j.bioorg.2019.103020_b0220","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejmech.2017.04.057","article-title":"Structural characterization of Giardia duodenalis thioredoxin reductase (gTrxR) and computational analysis of its interaction with NBDHEX","volume":"135","author":"Brogi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103020_b0225","doi-asserted-by":"crossref","first-page":"22431","DOI":"10.1039\/C5RA01170A","article-title":"Plasmodium falciparum subtilisin-like protease 1: discovery of potent difluorostatone-based inhibitors","volume":"5","author":"Giovani","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2019.103020_b0230","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/cmdc.201700759","article-title":"Development of potent inhibitors of the mycobacterium tuberculosis virulence factor zmp1 and evaluation of their effect on mycobacterial survival inside macrophages","volume":"13","author":"Paolino","year":"2018","journal-title":"Chemmedchem"},{"key":"10.1016\/j.bioorg.2019.103020_b0235","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1021\/acs.jmedchem.5b01812","article-title":"Development and pharmacological characterization of selective blockers of 2-arachidonoyl glycerol degradation with efficacy in rodent models of multiple sclerosis and pain","volume":"59","author":"Brindisi","year":"2016","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819303979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819303979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:49:49Z","timestamp":1758613789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819303979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":47,"alternative-id":["S0045206819303979"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103020","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridged bicyclic 2,3-dioxabicyclo[3.3.1]nonanes as antiplasmodial agents: Synthesis, structure-activity relationships and studies on their biomimetic reaction with Fe(II)","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103020"}}